FDA Seeks PacBio Sequencer for Rapid Pathogen ID
January 25, 2011
FDA Seeks PacBio Sequencer for Rapid Pathogen ID
The FDA "anticipates the need for a Pacific Biosciences genomic sequencer … for developing novel tools to reduce the time necessary to effectively identify/serotype/subtype critical foodborne pathogens."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Outbreak Tracking and Monitoring Emerges as Key Application for NGS in 2012
December 19, 2012 / Clinical Sequencing News - ABRF to Present Sequencing Platform Performance Study Next Week
March 13, 2012 / In Sequence - Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test
August 9, 2011 / Clinical Sequencing News - People in the News
August 9, 2011 / Clinical Sequencing News - Launch of PacBio RS Drives Q2 Revenue, but Investors Raise Concerns Over Pace of Uptake
August 9, 2011 / In Sequence